RxDoctor Payments Data

Amanda Kanski, APRN

Family · Round Rock, TXNPI 1184238735

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,227 of the $1,367 with a category attached, or 89.8%. It is spread thinly across 19 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $606, more than ten times the $11 reported in 2021.

$1,367in general payments, 2019–2025

Across 44 payments — averaging $31.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • TG Therapeutics, Inc.$216
  • AstraZeneca$180
  • Takeda Pharmaceuticals U.S.A., Inc.$163
  • Radius Health, Inc.$140
  • Amgen$131
  • Daiichi Sankyo Inc.$97
  • plus $440 from 13 others

What the payments were for

  • Food & beverage$1,22790%
  • Education$14010%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,367 in reported general payments places this provider in the 75th percentile of 15,456 family providers in Texas.

See all family providers in Texas →

Medicare billing

Part B allowed, 2024
$4,241,577
Medicare patients
531
Services billed
170,115

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin11$192

Paid to pharmacies, not to this prescriber.

Other family in Round Rock

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →